Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
7 results
  1. Langerhans Cell Histiocytosis Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65799
    ... MEK inhibitors (e.g., dabrafenib/trametinib and vemurafenib/cobimetinib). These agents and combinations are approved for adults ... PA, Dréno B, et al.: Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med ...
  2. Nausea and Vomiting Related to Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66056
    ... to 30% of patients: - Afatinib. - Alectinib. - Axitinib. - Capecitabine. - Cobimetinib. - Dabrafenib. - Dasatinib. - Etoposide. - Everolimus. - Fludarabine. - Ibrutinib. - Idelalisib. - Ixazomib. - ...
  3. Childhood Astrocytomas Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65944
    ... J, Condette Auliac S, et al.: Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma. ...
  4. NLM Digital Collections - Cutaneous melanoma : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), January 2017
    resource.nlm.nih.gov/101714786
    ... Interventions: • BRAF inhibitors (vemurafenib, dabrafenib) • MEK inhibitors (trametinib, cobimetinib) • immunotherapy (ipilimumab, pembrolizumab, nivolumab, interferon interleukin-2) • chemotherapy ( ...